MoneyWorks4Me

The total revenue for the quarter ended March 2025 remained nearly unchanged at Rs. 123.24 millions.The Net Loss for the quarter ended March 2025 is Rs. -33.93 millions as compared to Net Profit of Rs. 5.42 millions of corresponding quarter ended March 2024Operating profit surged to 11.39 millions from the corresponding previous quarter of 10.85 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 123.24 122.07 0.96 501.95 479.75 4.63 501.95 479.75 4.63
Other Income 0.87 0.82 6.10 3.08 3.21 -4.05 3.08 3.21 -4.05
PBIDT 11.39 10.85 4.98 41.90 15.89 163.69 41.90 15.89 163.69
Interest 0.69 1.48 -53.38 4.15 6.76 -38.61 4.15 6.76 -38.61
PBDT 10.70 9.37 14.19 37.75 9.13 313.47 37.75 9.13 313.47
Depreciation 1.03 0.94 9.57 3.85 3.68 4.62 3.85 3.68 4.62
PBT 9.67 8.43 14.71 33.90 5.45 522.02 33.90 5.45 522.02
TAX 43.60 3.01 1348.50 43.69 3.01 1351.50 43.69 3.01 1351.50
Deferred Tax 7.79 3.01 158.80 7.88 3.01 161.79 7.88 3.01 161.79
PAT -33.93 5.42 -726.01 -9.79 2.44 -501.23 -9.79 2.44 -501.23
Equity 74.20 74.20 0.00 74.20 74.20 0.00 74.20 74.20 0.00
PBIDTM(%) 9.24 8.89 3.98 8.35 3.31 152.03 8.35 3.31 152.03
Peers
Company Name CMP
Sun Pharma. Inds. 1852.65
Dr. Reddys Labs. 1200.50
Cipla 1412.95
Lupin 2092.30
Zydus Lifesciences 1192.95
View more..